Member Info for Dingodog1

Adapting the tech and getting it to successfully detect and monitor covid was a hurdle overcome months ago.

Getting government interest and securing contracts is the current hurdle. This RNS confirms the interest, and if it works as well as GB confirms it to then i can't see the UK gov saying "no"

Let's be honest, they know the economics as part of the trial. They probably wouldn't even entertain a trial if they expected to say "no" upon success

Good times ahead i feel

I believe someone said that there are 4,000 wastewater treatment plants in the UK. £80k a pop (if trial successful and the gov adopt it) would be revenues of £320m! Easily afordable to the UK gov.

China/cork can produce up to 200 units a month, so it would take just under two years to kit out the UK's waste water treatment plants.

All based on a successful trial and adoption, but fact the UK gov have even launched this trial means they are interested. Exciting times

I recall GB mentioning that COP26 could highlight some interesting news. This was a few weeks back in an interview.

COP26 is next week and we already know that the next generation units have been shipped to the UK, india and china.

One of the discussion points of COP26 is wastewater treatment and re-use of it.

What are the chances that we get some big news re PD in the next week or so? Whether from the company directly or not, the agenda at COP26 will discuss wastewater and the information that comes from that may well outline a plan or product that could be introduced. Given we are the leading (only?) company that can provide instantaneous results it would be pretty exciting if any reference is made to a "could be" DVRG product

£84k has come from their own pockets, similar to a PI investing. S&S have stuck around £25-30k in each as one of the directors put in less.

The cash reserves of the company has nothing to do with this transaction

Directors sinking £84k into the company, not a bad sign at all. They wouldn't do this if they didnt see significant value in doing so. Victory alone (should they find a buyer) will result in a large return alone

I think this is daybreak:

https://www.marketwatch.com/investing/stock/dbrm

$0.033 x 160m shares = $5.28m / £3.8m value to RBD if so

However, that SP is based on a current mcap of $2.12m and presumably does not reflect the new assets, but presumably pre-dilution.

That's all based on it being the same company

*been

Its be $0.58 for weeks. Not sure why they are suggesting up by 8.5%

Was due to take 12 months, they did it in just over 1. Wow. Roughly one merchant per day. That is a decent onboarding rate and bodes well for future merchants!

And thanks Jimbo333

Is this the first disclosure of shopify? Ive heard of them, but never used them. Would this be a major merchant addition?

Sounds good. Staggers, do you have a link?

12 months for 30 merchants would be a concern if that is an indication of how long it takes to set up a merchant.

Hopefully 12 months was because THG didnt want to go all in at the start and instead wished to pace it out. It would hopefully allow MODE to fine tune.

If sites are being added quicker it suggests that MODE has had a successful early period and that THG are happy to speed up.

The key to MODE's success needs to be its ability to scale. If it were to become a household name then we need it to be scalable and something that can be adopted in a few days tops. Waiting weeks/months for MODE per merchant will be a major issue

the following websites:

https://modeapp.com/mode-partner-merchants

I just checked zavvi with a dummy run. Mode is a payment option. Not sure if this has been mentioned on this BB yet

Great post drshan.

At this price the world is our oyster. If we were to focus on a hypothetical here, how much would the following be worth:

- the worlds premier (only?) water surveillance company that provides instant feedback on contamination and a first line of detection in a pandemic (local or global)

- the worlds premier point of use illness detection device that can detect all sorts of illnesses at the exhale of a breath

- the worlds only "DIY" skin microbiome evaluation tool that tells you the products that work for your skin. £85 and you go straight to the right product instead of spending thousands on products driven by corporate PR

- the premier (and only?) skin testing product in a world where animal testing has been outlawed.

A little ahead of myself, but very much a possibility, however slim. And all of this for £50m on 7 October 2021?

And the data... boy howdy the data! A company in the position of that described above would be worth ££££

But what do you think?

POLX also required the inhalation of xenon gas. BT only requires the inhalation of saline solution and the expelling of moistened breath. I dont think there will be any associated health risks

We have many shots on goal, i just wonder how good the goalie is!

Completely agree pilgrim, and i dont doubt the potential behemouth that DVRG can become. However, i want to welcome chat that focuses on any potential downsides. I feel it is healthy to open a wider range of opinions than a fan boy echo chamber. A view of the wider risks associated with the DVRG offering will appropriately prepare for what may be coming down the line.

The sorry souls in POLX felt that they had nailed on FDA approval that would take their brilliant tech to the moon. 90% chance of success per a broker. Guess what? It didnt get approval and the SP fell 70% costing many investors thousands. Could such an event happen to DVRG? These are the discussions i want us to consider

As i sit in the car during a 4 hour drive to cornwall (penzance, pretty much as far west as possible!) I am mulling over the risks to DVRG and its many offerings. All opinions welcome, i think this could be an interesting topic:

Skin trust club
Already "live" and will enter the US and China in 2022. The only risk i can think of here is that it isnt widely adopted and is seen as a fad/too expensive. The early take up without promotion suggests otherwise. Skin trust club could be massive. Dont forget the value of the data!

Labskin
Already in operation and used by most of the top 20 skincare companies. Cant really think of any risks here other than a competitor coming onto the market, but ultimately we have the long standing relationships. The main competitor atm is the use of animals. Both controversial and unethical imo

Microtox (BT, PD etc)
Biggest risk is that it doesnt get widely adopted by governments/countries. There is a chance of a competitor but once the CR deal gets across the line (perhaps a risk it doesnt!) we can scale up to the extent that a rival would need both better tech and very deep pockets. Regarding BT it is possible it fails to get through the testing process or some of the other breath tests get to market first and leave BT in their dust.

BT is probably the riskiest iron in the DVRG fire in terms of commercial traction, but STC, labskin and PD will offer a lot of value in time. All imo, but DVRG may well be on track to that golden unicorn status.

I welcome additional drawbacks as i want us to have a rounded view of the potential risks and set backs that could be on the horizon. The positives are plentiful and well documented, so lets become the devils advocate and encourage some balanced views

It popped at 2pm, around the time the US opens. Coincidence? Or is the OTC listing starting to have an effect?

The recent broker change was to open up other avenues and the recent awards ceremony appearance by Jannis Legler can only have helped the cause.

Very early days but nice to see us back in the 40's!

Over the past couple of days the directors have bought 141,084 shares which is worth over £50k based on the SP at the time of purchases.

This indicates two things. The first that they are in a free period (usually around the time the accounts are issued) and the second is that they dont hold any materially sensitive information that would prohibit a purchase (insider info).

The fact the directors have sunk £50k into MODE is a sign to me that the eventual raise (likely 2022) will be at a price well in excess of the 38p or so of the purchases. They wouldnt collectively spend that much if they were expecting it to be diluted imminently to a value of say £30k, they would just wait.

It is likely that they expect said £50k to become, say, £100k before being diluted to say £80k. And they would have a better idea than us, that is for sure. If you are on a sinking ship you dont chuck more money at it.

MODE will come good, but we must wait